7th Circ. Blocks Boehringer Workers' Depos In Pradaxa MDL

Law360, New York (January 3, 2014, 9:06 PM EST) -- The Seventh Circuit on Thursday temporarily blocked Germany-based Boehringer Ingelheim International GmbH employees from being deposed in the U.S. in personal injury multidistrict litigation over the blood thinner Pradaxa, after the drugmaker argued a lower court overstepped its authority.

In a Dec. 9 order penalizing the company for discovery abuses, an Illinois federal judge ordered BII and U.S. unit Boehringer Ingelheim Pharmaceuticals Inc. to make foreign employees available for depositions in New York City or elsewhere in the U.S. The judge hit the drugmakers with a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.